about
"Christmas Balls": a Christmas carol by the adolescent cancer patients of the Milan Youth Project.Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.Effects of celecoxib on prostanoid biosynthesis and circulating angiogenesis proteins in familial adenomatous polyposis.Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer.Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancerWireless capsule endoscopy in adolescents with familial adenomatous polyposis.Serum soluble urokinase-type plasminogen activator receptor as a serum marker of inflammatory response that leads to tissue damage and surgical complication.Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.Risk of desmoid tumours after open and laparoscopic colectomy in patients with familial adenomatous polyposis.Integrative approach for prioritizing cancer genes in sporadic colon cancer.BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.Laparoscopic colectomy and restorative proctocolectomy for familial adenomatous polyposis.Phosphatase Protein Homologue to Tensin Expression and Phosphatidylinositol-3 Phosphate Kinase Mutations in Colorectal CancerQuantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancerComment on Ueno et al.: Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in JapanShort-term and long-term outcomes after preventive surgery in adolescent patients with familial adenomatous polyposisRisk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort
P50
Q30396769-0062C8AA-50F4-48BB-B740-535F980FF257Q34582442-6D1346C1-FE8F-4FCD-B1C0-81FA6DF0716EQ35847666-334710F5-4B1F-44A6-8AE4-0AC5345153A9Q36393854-213DA2BC-F7AA-4EAC-A712-EE47A6402F56Q36980711-F021E339-169F-4838-B349-317F969A5573Q38556284-F0BD7CAC-8C0C-4CE5-BC6B-612E61044D18Q47376040-7EED0689-DC5E-48C9-B5BD-D8C9C627B80DQ51104081-72A9CA5E-0C1F-4885-81E3-4BB389EEE720Q51163895-EBC662CD-20BE-4E81-AA3A-80D4760E0E1DQ51802432-DB1687BC-7094-46B8-A1B0-EEA74489DF4AQ54334013-DD04CDF9-E15E-4468-B408-0A794BB642DAQ54374432-0F5A64A8-254F-4DC1-B441-B76E797F6F82Q57280984-E103B479-0267-48C5-A419-A9E46549A19BQ58813330-2CE375F7-FAF2-4326-A788-DA8F3D0BF4A5Q89032111-622ECFBA-59BB-4CA5-9C39-1F1365F46AC8Q91703565-23261949-134B-4A15-BB19-DFE3B53B7339Q95278040-EA70FEDB-43D7-4259-8CE6-4A14AC26F871
P50
description
researcher ORCID ID = 0000-0002-5037-9077
@en
wetenschapper
@nl
name
Stefano Signoroni
@ast
Stefano Signoroni
@en
Stefano Signoroni
@es
Stefano Signoroni
@nl
type
label
Stefano Signoroni
@ast
Stefano Signoroni
@en
Stefano Signoroni
@es
Stefano Signoroni
@nl
prefLabel
Stefano Signoroni
@ast
Stefano Signoroni
@en
Stefano Signoroni
@es
Stefano Signoroni
@nl
P106
P1153
23989698400
P21
P31
P496
0000-0002-5037-9077